Filter
426
Text search:
drug
import
Featured
Recommendations
27
New Publications
123
Language
Document type
No document type
232
Studies & Reports
81
Guidelines
68
Manuals
17
Strategic & Response Plan
16
Training Material
4
Situation Updates
3
Fact sheets
3
Resource Platforms
2
Countries / Regions
India
24
Global
15
South Africa
14
Uganda
12
Nepal
12
Western and Central Europe
12
Sierra Leone
11
Kenya
11
Liberia
10
Nigeria
10
Tanzania
9
Ghana
8
Zimbabwe
8
South–East Asia Region
8
Ethiopia
7
Zambia
7
Rwanda
7
Bangladesh
7
Malawi
6
Ukraine
5
Myanmar / Burma
5
Venezuela
5
Burkina Faso
4
Senegal
4
Syria
4
Indonesia
4
Namibia
4
Eswatini/ Swaziland
4
Mozambique
3
Lesotho
3
Latin America and the Carribbean
3
Africa
3
Eastern Europe
3
Congo, Democratic Republic of
2
Haiti
2
Iraq
2
Germany
2
Lebanon
2
Cambodia
2
China
2
Benin
2
Botswana
2
West and Central Africa
2
Middle East and North Africa
2
Western Pacific Region
2
Laos
2
Jamaica
2
Guinea
1
USA
1
Cameroon
1
Philippines
1
Pakistan
1
South Sudan
1
Jordan
1
Afghanistan
1
Thailand
1
Argentina
1
Peru
1
Brazil
1
North Macedonia
1
Serbia
1
Colombia
1
Bolivia
1
Sri Lanka
1
Chile
1
Yemen
1
East and Southern Africa
1
Asia
1
Bhutan
1
Poland
1
North Korea
1
Albania
1
Timor Leste/ East Timor
1
Tajikistan
1
Russia
1
Moldova
1
Iran
1
Kyrgyzstan
1
Kazakhstan
1
Vietnam
1
Gabon
1
Denmark
1
Maldives
1
Mauritius
1
Authors & Publishers
Publication Years
Category
Countries
207
Clinical Guidelines
35
Public Health
24
Key Resources
11
Pharmacy & Technologies
11
Women & Child Health
5
Toolboxes
AMR
58
HIV
32
Mental Health
30
Pharmacy
26
TB
23
COVID-19
19
Rapid Response
11
Ebola
7
Conflict
7
NCDs
7
Caregiver
5
Global Health Education
3
Planetary Health
3
NTDs
3
Natural Hazards
2
Specific Hazards
2
Health Financing Toolbox
2
Disability
1
Cholera
1
Zika
1
Social Ethics
1
Examination of the business behavior of Boehringer Ingelheim, Bayer and Baxter in India
Act 851 | AN ACT to revise and consolidate the law relating to public health to
prevent disease, promote, safeguard, maintain and protect the health
of humans and animals and to provide for related matters.
Application of a One Health approach .
The present guidance was developed with the support of the WHO Advisory Group on Integrated Surveillance of Antimicrobial Resistance (AGISAR) to assist countries and other stakeholders in the establishment and development of programmes of integrated surveillan
...
This guideline is intended to provide recommendations to applicants wishing to submit applications for the registration of medicines. It represents the Medicines Control Council’s current thinking on the safety, quality and efficacy of medicines.
CHAPTER 15:03 | Acts 14/1969, 62/1971, 35/1974, 20/1978, 41/1978 (s. 35) 39/1979, 7/1987, 11/1988, 18/1989 (s. 27), 1/1996, 6/2000, 22/2001; R.G.N. 899/1978.
HRH SA 2030 | Draft HR Strategy for the Health Sector: 2012/13 – 2016/17 Consultation Document
A review of available evidence (2016).
28-29 June 2016; Geneva, Switzerland
The END TB strategy.
Accessed November 2017
